Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gliosarcoma × Immunotherapy, Adoptive × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma, B-Cell 12 Lymphoma, Non-Hodgkin 11 Recurrence 9 Burkitt Lymphoma 8 Lymphoma 7 Multiple Myeloma 6 Neoplasms 5 Lymphoma, Mantle-Cell 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Pancreatic Neoplasms 4 Lymphoma, Follicular 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Hematologic Neoplasms 4 Carcinoma, Hepatocellular 4 Nasopharyngeal Carcinoma 3 Leukemia, B-Cell 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Stomach Neoplasms 2 Simpson-Golabi-Behmel syndrome 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Osteosarcoma 2 Neoplasm, Residual 2 Melanoma 2 Lymphoma, B-Cell, Marginal Zone 2 Glioma 2

Interventions

Temozolomide 80 Radiotherapy 47 Bevacizumab 29 Irinotecan 18 Radiation 15 Erlotinib Hydrochloride 14 Carmustine 13 Magnetic Resonance Spectroscopy 12 O(6)-benzylguanine 10 Chemotherapy, Adjuvant 10 sargramostim 8 Thalidomide 8 Imatinib Mesylate 8 Carboplatin 8 Gene Expression Profiling 6 Filgrastim 6 Drug Therapy 6 Surgical Procedures, Operative 5 Radiotherapy, Intensity-Modulated 5 Hydroxyurea 5 Gefitinib 5 pembrolizumab 4 aldesleukin 4 Topotecan 4 Immunohistochemistry 4 Etoposide 4 Dasatinib 4 Celecoxib 4 Biopsy 4 Aminolevulinic Acid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02664363 2023-02-17

ExCeL

Duke University

Phase 1 Terminated

3 enrolled 8 charts

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡